Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 159-166 , September 2009

Photofrin PDT for early stage oesophageal cancer: Long term results in 40 patients and literature review

  • K. Moghissi

      Affiliations

    • Yorkshire Laser Centre, UK
    • ,
  • Kate Dixon, BA Hons

      Affiliations

    • Yorkshire Laser Centre, UK
    • Corresponding Author InformationCorresponding author at: The Yorkshire Laser Centre, Goole & District Hospital, Woodland Avenue, Goole, East Yorkshire DN14 6RX, UK. Tel.: +44 01724 290456; fax: +44 01724 290456.
    • ,
  • Mark Stringer

      Affiliations

    • Yorkshire Laser Centre, UK
    • University of Leeds, UK
    • ,
  • J.A.C. Thorpe

      Affiliations

    • Yorkshire Laser Centre, UK
    • St James Hospital, Leeds, UK

References 

  1. Toreck F. The first successful case of resection of the thoracic oesophagus for carcinoma. Surg Gynaecol Obstet. 1913;16:614–617
  2. Ohsawa T. Surgery of the oesophagus. Arch Jap Chir. 1933;10:605;[quoted by Franklin RH, in Surgery of the oesophagus 1952 Edward Arnold Publishers, London, 149pp]
  3. Turner GG. Excision of thoracic oesophagus for carcinoma with reconstruction of an extra thoracic gullet. Lancet. 1933;2:1315–1319
  4. Lewis I. The surgical treatment of carcinoma of the oesophagus with special reference to a new operation for growth of the middle third. Br J Surg. 1946;34:18–31
  5. Moghissi K. General technique related to operations of the oesophagus. In Moghissi's Essential of Thoracic & Cardiac Surgery 2nd ed. in Moghissi K, Thorpe JAC, Cuilli F, Elsevier, 2003, p. 409–417.
  6. Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photodynamic Therapy for the treatment of malignant tumours. Cancer Res. 1978;38:2620–2635
  7. McCaughan JS, Guy JT, Hawley P, et al. Haematoporphyrin derivative and photo eradication therapy of malignant tumours. Laser Surg Med. 1983;3:199–209
  8. Hayata Y, Kato H, Okitsu H, Kawagughi M, Konaka C. Photodynamic Therapy with haematoporphyrin derivative in cancer of the upper gastro-intestinal tract. Semin Surg Oncol. 1985;1:1–11
  9. McCaughan JS, Williams TE, Bethel BM. Palliation of oesophageal malignancy with Photodynamic Therapy. Ann Thoracic Surg. 1985;40:113–120
  10. Moghissi K, Dixon K, Hudson E, Stringer M. Photodynamic Therapy for esophageal cancer. Laser Med Sci. 1995;10:67–71
  11. Moghissi K, Dixon Kate , Thorpe JAC, Stringer M. The role of Photodynamic Therapy (PDT) in inoperable oesophageal cancer. Eur J Cardiothorac Surg. 2000;17:95–100
  12. Sobin LH, Wittekind CH. UICC: TNM classification of malignant tumours. 6th ed.. New York: Wile-Liss; 2002;
  13. Kaplan-Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc. 1958;78:457–488
  14. UK Oesophageal cancer (Gillett) http:info.cancerresearchUK. org/cancerstats/types/oesophagus.
  15. National Cancer Institute. A snapshot of Esophageal Cancer. http:II planning cancer. Gov.disease/Esophageal-snapshop.pdf.
  16. Kato H, Tachimori Y, Wantabe H, Yamaguchi H, Ishihawa T, Itabaghi M. Superficial oesophageal carcinoma. Surgical treatment and the results. Cancer. 1990;66:2319–2323
  17. Moghissi K. Surgical resection for Stage I cancer of the oesophagus and cardia. Br J Surg. 1992;79:935–937
  18. Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewart JR. Early oesophageal cancer. Pattern of lymphatic spread and prognostic factors for long term survival after surgical resection. Ann Surg. 2005;242:566–577
  19. Sawant D, Moghissi K. Management of unresectable oesophageal cancer. A review of 537 patients. Eur J Cardiothorac Surg. 1994;8:113–117
  20. Sujendran V, Sica G, Warren B, Maynard N. Oesophagectomy remains the gold standard for treatment of high grade dysplasia in Barretts esophagus. Eur J Cardiothorac Surg. 2005;28:763.6
  21. Tharavei C, Hagen JA, Peters JH, Portale G, et al. Predictive factors of coexisting cancer in Barrett's high grade dysplasia. Surg Endosc. 2006;20:439–443
  22. Williams VA, Watson TJ, Herbella FA, Gellarsen O, et al. Oesophagectomy for high grade dysplasia is safe, curative and results in good alimentary outcome. J Gastro Intestinal Surg. 2007;11:1989–1997
  23. Konda VI, Ross AS, Ferguson MK, Hart JA, Lin S, et al. Is the risk of concomitant invasive oesophageal cancer in high grade dysplasia in Barrett's oesophagus over-estimated. Clin Gastroenterol Hepatol. 2008;6:159–164
  24. Zaninotto G, Parenti AR, Ruol A, Constantini M, Merigwano S, Ancon E. Oesophageal resection for high grade dysplasia in Barrett's oesophagus. Br J Surg. 2000;87:1102–1105
  25. Downs-Kelly , Mendelin JE, Bennett AE, Castilla E, et al. Poor inter-obsever agreement in the distinction of high grade dysplasia and adeno carcinoma in pre treatment Barrett's oesophagus biopsies. Am J Gastroenterol. 2008;103:2333–2340
  26. Schiperman RJ, Riddle RH, Kato Y, et al. The Vienna classification of gastro intestinal epithelial neoplasia. Gut. 2000;47:251–255
  27. Kato H, Kito T, Furuse K, Sakai E, Ito K, et al. Abstract: Photodynamic Therapy in the early treatment of cancer. Gan to Kagaku Ryoho. 1990;17:1833–1838
  28. Sibille A, Lambert R, Souquet JC, Sabben G, Decos F. Long term survival after photodynamic therapy for esophageal cancer. Gastro Enterology. 1995;1008:3378–3384
  29. McGaughan JS, Ellison C, Guy JT, et al. Photodynamic therapy for esophageal malignancy: a prospective 12 year study. Ann Thorac Surg. 1996;62:1005–1010
  30. Savary JF, Grosjean P, Monnier P, et al. Photodynamic therapy of early squamous cell carcinoma of the esophagus: a review of 31 cases. Endoscopy. 1998;30(3):258–265
  31. Radu A, Grosjean P, Fontolliet C, Wagnieres G, et al. Photodynamic Therapy for 101 early cancers of the upper aero digestive tract, the oesophagus and the bronchi: a single-institution experience. Diagn Ther Endos. 1999;5:145–245
  32. Moghissi K, Dixon K. Photodynamic Therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years experience. Technol Cancer Res Treatment. 2003;2:319–325
  33. Javaid B, Watt P, Krasner N. Photodynamic Therapy (PDT) for esophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorine): a preliminary study. Laser Med Sci. 2002;17:135
  34. Etienne J, Dorme N, Bourg-Heckly G, Raimbert P, Flejou JF. Photodynamic Therapy with green light and m-tetrahydroxyphenyl chlorine for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc. 2004;59:880–889
  35. Lovat LB, Jamieson NF, Novelli MR, et al. Photodynamic therapy with m-tetrahydroxyphenyl chlorine for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc. 2005;62:617–623
  36. Allison RR, Bonnie GH, Cuenca R, Hu XH, et al. Photo sensitizers in clinical PDT. Photodiagn Photodyn Ther. 2004;1:27–42
  37. Gossner L, May A, Sroka R, Stolte M, Hahn EG, Ell C. Photodynamic destruction of high grade dysplasia and early carcinoma of the oesophagus after the oral administration of 5 aminolevulenic acid. Cancer. 1999;86:1921–1928
  38. Tan WC, Fulljames C, Stone N, et al. Photodynamic Therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. Photochem Photobiol B. 1999;53:75–80
  39. Pech O, Gossner L, May A, et al. Long term results of photodynamic therapy with 5-aminilevulinic acid for superficial Barrett's cancer and high grade intraepithelial neoplasia. Gatrointest Endosc. 2005;62:24–30
  40. Peters F, Kara M, Rosmolen W, et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia an dearly cancer in Barrett's esophagus after endoscopic resection. Endoscopy. 2005;37:418–424
  41. Orth K, Stanescu A, Ruck A, Russ D, Beger HG. Photodynamic ablation and argon-plasma coagulation of premalignant and early stage malignant lesions of the oesophagus—an alternative to surgery?. Chirurg. 1999;70:431–438
  42. Huang R. Photodynamic Therapy in china: over 25 years of unique clinical experience. Part two. Clinical experience. Photodiagn Photodyn Ther. 2006;3:71–84
  43. Huang I. Photodynamic Therapy in china: ver 25 years of unique clinical experience. Part one. History and domestic photosensitisers. Photodiagn Photodyn Ther. 2006;3:1–3
  44. Filonenko EV, Sokolov VV, Chissov VI, Lukyanets EA, Vorozhtsov GN. Photodynamic Therapy of early oesophageal cancer. Photodiagn Photodyn Ther. 2008;5(3):187–190
  45. Moghissi K. Procedure-related risks & hazards of endoscopic NdYAG laser & PDT of the upper aero-digestive tract: personal experience and literature review. Presented at the Joint BMLA/ELA International Laser Conference, September 2003. Edinburgh, Scotland. Laser Med Sci. 2003;18(1):S64
  46. Foroulis CN, Thorpe JAC. Photodynamic Therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Eur J Cardiothorac Surg. 2006;29:30–34
  47. Keeley SB, Pennathur A, Gooding W, Landrenequ RJ, Christie NA, Luketich J. Photodynamic Therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol. 2007;14:2406–2410
  48. Corti L, Skarlatos J, Boso C, et al. Outcome of patients receiving Photodynamic Therapy for early esophageal cancer. Int J Radiat Oncol Biol Phys. 2000;1(47):419–424
  49. Wolfsen HC, Woodward TA, Raimondo M. Photodynamic Therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc. 2002;77:1176–1181
  50. Overholt BF, Panjehpour M, Halberg DL. Photodynamic Therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long term results. Gastrointest Endosc. 2003;58:183–188
  51. Greenstein AJ, Wisnivesky JP, Litle VR. Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates. Dis Esophagus. 2008;21:673–678

PII: S1572-1000(09)00100-8

doi: 10.1016/j.pdpdt.2009.07.026

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 159-166 , September 2009

Article Tools

* Image Usage & Resolution